Importance of effective, early and sustained reperfusion during acute myocardial infarction
- 1 April 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (13), 912-916
- https://doi.org/10.1016/0002-9149(89)90138-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Early intervention in acute myocardial infarction: Significance for myocardial salvage of immediate intravenous streptokinase therapy followed by coronary angioplastyJournal of the American College of Cardiology, 1987
- Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?Circulation, 1986
- Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarctionJournal of the American College of Cardiology, 1986
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983